| Product Name | MF | CAS | Details |
|---|
| MGC50722 Blocking Peptide | Details |
| 4-Fluoro-2-methanesulfonamidobenzoic acid | C8H8FNO4S | 170107-84-3 | Details |
| 2-Cyclopropylpyrimidin-5-amine | C7H9N3 | 1152519-69-1 | Details |
| 2,4,7,8,9-Penta-O-acetyl-N-acetyl-3-fluoro-b-D-neuraminic acid methyl ester | C22H30FNO14 | 117405-58-0 | Details |
| Ethyl 6-methyl-3-oxooxane-2-carboxylate | C9H14O4 | 115399-62-7 | Details |
| 2-[4-(Thiophen-3-ylmethyl)piperazin-1-yl]ethan-1-ol | C11H18N2OS | 331858-57-2 | Details |
| Lead sulfide StremDots?￠ quantum dot (PbS core - ~3nm), 10 mg/mL in toluene, 1000nm peak emission | PbS | 1314-87-0 | Details |
| Afasevikumab | 1589503-30-9 | Details |
| tert-Butyl 3-(trifluoroacetamido)piperidine-4-carboxylate | C12H19F3N2O3 | 1909319-36-3 | Details |
| Propyl 2-acetamido-2-deoxy-b-D-glucopyranoside | C11H21NO6 | 70832-36-9 | Details |
| Isothipendyl hydrochloride | C16H19N3S.ClH | 1225-60-1 | Details |
| GDF5 protein | Details |
| NGB 2904 hydrochloride | C28H30Cl3N3O | 189061-11-8 | Details |
| 3-(5-Methyl-4H-1,2,4-triazol-3-yl)benzonitrile | C10H8N4 | 312772-65-9 | Details |
| Cucurbitacin A | C32H46O9 | 6040-19-3 | Details |
| Amino-dPEG?24-Tris(-dPEG?24- Tris (m-dPEG?24)3)3 | Details |
| LCBiot-SFIEDLLFNKVTLADAGF-OH | Details |
| 6-Sulfatoxy melatonin sodium salt | C13H17N2NaO6S | 76290-78-3 | Details |
| 4-Nitro-2-(trifluoromethyl)benzaldehyde | C8H4F3NO3 | 50551-17-2 | Details |
| N-Phenylpiperidine-3-sulfonamide hydrochloride | C11H17ClN2O2S | 1989659-77-9 | Details |
| 3-Iodo-2-methylpyridine | C6H6IN | 15112-62-6 | Details |
| U89232 | C19H25N5O2 | 134017-78-0 | Details |
| 3-Chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine | C9H9ClN4 | 29334-67-6 | Details |
| trans-2-Dodecenoic Acid | C12H22O2 | 32466-54-9 | Details |
| 3-Nitrophenol | C6H5NO3 | 554-84-7 | Details |
| 3-(Furan-2-carboxamido)propanoic acid | C8H9NO4 | 5652-37-9 | Details |
| Alpha crystallin B antibody | Details |
| 2-Benzamido-2-deoxy-D-glucopyranose | C13H17NO6 | 14086-91-0 | Details |
| 5-Chloro-3-ethynylpyridin-2-amine | C7H5ClN2 | 866318-88-9 | Details |
| rac-(4aR,8aR)-Decahydroquinoline-1-sulfonamide | C9H18N2O2S | 1592402-25-9 | Details |
| Fmoc-iminodiacetic acid | C19H17NO6 | 112918-82-8 | Details |
| Cixutumumab | 947687-12-9 | Details |
| IFNA13 antibody | Details |
| H-VCWGELMNL-OH | Details |
| Phenyl 2-Deoxy-1-thio-2-(2,2,2-trichloroethoxyformamido)-b-D-galactopyranoside | C15H18Cl3NO6S | 868230-98-2 | Details |
| 4-[4-(3-Chloroprop-1-yn-1-yl)phenoxymethyl]-1-methyl-1-pyrazole | C14H13ClN2O | 1178208-11-1 | Details |
| 2-Amino-2-(2,4,6-trimethylphenyl)ethan-1-ol hydrochloride | C11H18ClNO | 2172054-14-5 | Details |
| Horse IgM ELISA Kit | Details |
| 2-Naphthylhydrazine | C10H10N2 | 2243-57-4 | Details |
| 2,5-(2-Chlorophenyl)-phenyl-1,3,4-triazole | C20H13Cl2N3 | 88032-13-7 | Details |
| 1-(3,3-difluorocyclopentyl)-ethanone | C7H10F2O | 1202077-00-6 | Details |
| beta-Endorphin (1-27), human | C158H251N39O46S | Details |
| N-De-2,4-difluorobenzyl dolutegravir | C13H15N3O5 | 1485081-26-2 | Details |
| (S)-3-(4-Boc-piperazin-1-yl)-2-(Fmoc-amino)propionic acid | C27H33N3O6 | 313052-20-9 | Details |
| 3-(Hydroxymethyl)cyclopentanone | C6H10O2 | 113681-11-1 | Details |
| 7-Hydroxy coumarin 2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester | C22H22O12 | 168286-97-3 | Details |
| 2,3,4,5,6-Pentachloro-1-fluoropyridin-1-ium trifluoromethanesulfonate | C6Cl5F4NO3S | 130433-70-4 | Details |
| 2-((2-carboxycyclopropyl)carbonylamino)-6-methylbenzoic acid | C13H13NO5 | 1274891-95-0 | Details |
| PPIF antibody | Details |
| 2-Phenyl-1,2,5-thiadiazolidine-1,1-dione | C8H10N2O2S | 503310-73-4 | Details |
| 5-(Oxane-4-carbonyl)-1,3-thiazol-2-amine | C9H12N2O2S | 2168395-00-2 | Details |
| Fenofibrate | C20H21ClO4 | 49562-28-9 | Details |
| Terbutryn-d9 | C10H10D9N5S | 1246817-01-5 | Details |
| 2-Amino-N-(propan-2-yl)-N-propylbenzamide | C13H20N2O | 1094866-20-2 | Details |
| GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
| 4-O-Benzyl-D-galactal | C13H16O4 | 157380-76-2 | Details |
| [Des-Gly77,His78] Myelin Basic Protein (68-84), bovine | C71H113N23O28 | 98474-59-0 | Details |
| 7-Phenyl-2,3,4,5-tetrahydro-1H-1,4-diazepin-5-one | C11H12N2O | 57552-95-1 | Details |
| 2-(2,4-Dihydroxybenzoyl)terephthalic acid | C15H10O7 | 1819991-87-1 | Details |
| 1-[2-Chloro-5-(trifluoromethyl)phenyl]-1H,4H,5H,6H-cyclopenta[C]pyrazole-3-carboxylic acid | C14H10ClF3N2O2 | 926187-51-1 | Details |
| (2R,4R)-1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-4-methoxypyrrolidine-2-carboxylic acid | C21H21NO5 | 2137090-83-4 | Details |
| Rutamarin | C21H24O5 | 13164-05-1 | Details |
| SPN protein (His tag) | Details |
| 3,3-Difluoro-1-(pyridin-3-yl)cyclobutane-1-carboxylic acid hydrochloride | 2225146-93-8 | Details |
| 2-Chloro-N-[(5-cyano-2-fluorophenyl)methyl]-N-methylacetamide | C11H10ClFN2O | 1178818-50-2 | Details |
| RIMKLA antibody | Details |
| GRTP1 antibody | Details |
| 4-Amino-7-(β-D-ribofuranosyl)-7H-pyrrolo[2.3-d]pyrimidine-5-carboxylic acid | C12H14N4O6 | 18418-00-3 | Details |
| Anti-phospho-PLEKHS1 (pY248) antibody - 0.5mg/mL | Details |
| 3,5-Dimethyl-N-(piperidin-4-yl)furan-2-carboxamide hydrochloride | 1840265-41-9 | Details |
| 1,2,3,4-Tetra-O-acetyl-6-deoxy-6-fluoro-D-galactopyranose | C14H19FO9 | 155488-15-6 | Details |
| 4,4'-Sulfonylbis-morpholine | C8H16N2O4S | 5328-68-7 | Details |
| [3,4,4-Tris(hydroxymethyl)pyrrolidin-3-yl]methanol hydrochloride | 2193064-88-7 | Details |
| (1S)-1-(Isoquinolin-5-yl)ethan-1-ol | C11H11NO | 2227837-50-3 | Details |
| 4-(2-Fluorophenyl)-2-(pyrrolidin-2-yl)-1H-imidazole | C13H14FN3 | 1153102-36-3 | Details |
| 3-?Thia-?7-?azabicyclo[3.3.1]?nonane 3,?3-?dioxide hydrochloride | C7H14ClNO2S | 1690364-33-0 | Details |
| 3-Bromo-N-methyl-5-(trifluoromethyl)aniline hydrochloride | C8H8BrClF3N | 2155856-59-8 | Details |
| Ethyl 7-hydroxy-5-oxo-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-6-carboxylate | C15H15NO4 | 84088-84-6 | Details |
| Recombinant Human Ephrin-A3 | Details |
| 5H,6H,8H-Pyrano[3,4-d]pyrimidin-2-amine | C7H9N3O | 1781072-41-0 | Details |
| 3-Chloro-5-ethoxy-4-hydroxybenzonitrile | C9H8ClNO2 | 796067-63-5 | Details |
| GMF gamma antibody | Details |
| 6-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-8-fluoro-6-azaspiro[3.4]octane-8-carboxylic acid | C23H22FNO4 | 2137567-19-0 | Details |
| 2-Methylbutane-1-sulfonamide | C5H13NO2S | 854461-68-0 | Details |
| Carboxypeptidase X Blocking Peptide | Details |
| 4-{[(Prop-2-en-1-yl)amino]methyl}benzonitrile hydrochloride | C11H13ClN2 | 2287272-94-8 | Details |
| Fmoc-N-Me-D-Arg(Mtr)-OH | C32H38N4O7S | 2022956-31-4 | Details |
| 2-(4-Methylpiperidin-4-yl)-1,3-benzothiazole hydrochloride | C13H17ClN2S | 1803604-60-5 | Details |
| 7-(Chlorosulfonyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid | C9H7ClO6S | 66410-36-4 | Details |
| SARS-CoV-2 Antigen Peptide NCAP (AFFGMSRIGMEVTPSGTW) | Details |
| RGS6 Blocking Peptide | Details |
| 5-(2-Bromophenyl)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazole-3-thiol | C15H9BrF3N3S | 702646-09-1 | Details |
| 6,8-Dibromo-3,4-dihydroquinazolin-4-one | C8H4Br2N2O | 17518-85-3 | Details |
| 4-(4-(Isopropyl)phenyl)-2-(3-methyl-5-oxo-1-phenyl(2-pyrazolin-4-yl))-4-oxobutanoic acid | C23H24N2O4 | 937605-14-6 | Details |
| Methyl 4-bromo-3-hydrazinylbenzoate dihydrochloride | 1909317-33-4 | Details |
| P2Et Phosphazene | C12H35N7P2 | 165535-45-5 | Details |
| tert-Butyl 2-imino-2-oxo-2λ6-thia-6-azaspiro[3.3]heptane-6-carboxylate | C10H18N2O3S | 2225816-09-9 | Details |
| 5-Bromo-2,4-dimethylbenzonitrile | C9H8BrN | 807628-76-8 | Details |
| AQP2 antibody (Ser261) | Details |
| 1-[5-(2-Iodophenyl)thiophen-2-yl]-2-methylpropan-1-one | C14H13IOS | 1094282-10-6 | Details |
| Product Total： Product Page： | ||||
| 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 | ||||